Shares of BriaCell Therapeutics Corp (BCTX) fell over 8% in Thursday's after-hours trading as the Canadian biotech firm ...

BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in ...

The following is a summary of “Lymphovascular invasion is an independent predictor of metastasis and disease-specific death ...

Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast ...

Lymph node metastasis was uncommon among clinically node-negative PTC patients without evidence of nodal involvement on USG and CT.

Bangalore-based biotech startup Mestastop Solutions has been awarded the Best Metastasis R&D Specialist for 2025 by the ...

Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

Brain metastases become more prevalent with each line of therapy in metastatic breast cancer and are more common in patients with certain cancer subtypes, new research shows.

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...

Therapeutics confirms the sustained complete resolution of the lung metastasis, first reported in February 2025, two months ...

Lung metastasis in metastatic breast cancer patient fully resolved at 2 months, confirmed at 4 months post-Bria-OTS treatment. Patient showed stable disease elsewhere after lowest dose of Bria-OTS ...